ASTRO updates guideline on radiation therapy for HPV-related throat cancer

Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer

A new large-scale study, co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators, provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is equally as effective as conventional radiotherapy for prostate cancer, without compromising patient safety.

March 21, 2025

Vol.51 No.11

Clinical

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.

March 07, 2025

Vol.51 No.09

By Claire Marie Porter

Clinical Roundup

ASTRO issues first clinical guideline on radiation therapy for anal cancer

The American Society for Radiation Oncology issued a clinical guideline on the use of radiation therapy to treat adult patients with primary squamous cell carcinoma of the anal canal and anal margin.

March 07, 2025

Vol.51 No.09

Clinical Roundup

Vaginal microbiome differences linked to higher cervical cancer rates in Native American women, study finds

A recent study led by researchers at the University of Arizona Cancer Center and Northern Arizona University found that Native American women were disproportionately affected by vaginal dysbiosis, a disruption in the balance of bacterial that increases the risk of human papillomavirus infection, which can cause cervical cancer.

January 17, 2025

Vol.51 No.02

Clinical Roundup

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Data from Gardasil 9 studies reinforce importance of gender-neutral HPV vaccination in adults

Clinical and real-world data for the 9-valent human papillomavirus vaccine, Gardasil 9, evaluating the burden and incidence of certain HPV-related cancers and diseases, were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from Nov. 12-15.

November 15, 2024

Vol.50 No.43

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

YOU MAY BE INTERESTED IN

Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

ASTRO issues first clinical guideline on radiation therapy for anal cancer

Vaginal microbiome differences linked to higher cervical cancer rates in Native American women, study finds

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Data from Gardasil 9 studies reinforce importance of gender-neutral HPV vaccination in adults

Renew today!

Subscriber content

Never miss an issue!

Login

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

YOU MAY BE INTERESTED IN

Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer

Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it

ASTRO issues first clinical guideline on radiation therapy for anal cancer

Vaginal microbiome differences linked to higher cervical cancer rates in Native American women, study finds

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Data from Gardasil 9 studies reinforce importance of gender-neutral HPV vaccination in adults

Never miss an issue!

Login

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it